|
How's-it John. As for AQSE's financials, it is no secret that they need cash. Any start up company, especially a biotech, needs cash to get up and running. This companys efforts in tapping into investment capital may well of been partially successful with their deal with the Canadians. It's my understanding that the Canadians will fund the production of the algae. I don't know at this point if that means they will provide an infussion of capital to expand the facility. But even if they don't, I believe that this new relationship lends new credibility to AQSE and their vision. Don't forget, CYAN was a pure penny stock for years until they struck up a similar relationship with a big mainland corporation. Sure it's a long shot, but a reasonable one, in my humble opinion. And hey, at .30 per share, how badly can you get hurt. My goal is to own 100k shares, purchased a little bit at a time, by the turn of the century. I believe the upside potential is far greater than the downside risk. Best of luck to you. |
